List of insiders holdings for AERIE PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner (2)(3)(4) | 2015-06-22 17:08:25 | 1,237,466 0 | 1,237,466 | Form 13D |
| 2 | ACP IV L.P. JANNEY DANIEL NOHRA GUY P ACMP IV LLC 10% Owner | 2014-07-18 16:38:57 | 1,012,882 0 | 1,012,882 | Form 13D |
| 3 | SOFINNOVA VENTURE PARTNERS VII L P Sofinnova Management VII L.L.C. HEALY JAMES Buatois Eric POWELL MICHAEL 10% Owner | 2014-12-03 20:38:43 | 958,157 0 | 958,157 | Form 13D |
| 4 | Foresite Capital Management II LLC Foresite Capital Fund II L.P. Foresite Capital Fund III L.P. Foresite Capital Fund IV L.P. Foresite Capital Management III LLC Foresite Capital Management IV LLC Tananbaum James B. 10% Owner | 2020-06-12 15:09:53 | 837,907 0 | 837,907 | Form 13G |
| 5 | Mehra Anand Director | 2015-04-16 19:23:54 | 0 491,657 | 491,657 | Form 4 |
| 6 | RUBINO RICHARD J Chief Financial Officer | 2021-02-25 18:24:53 | 353,937 0 | 353,937 | Form 4 |
| 7 | ANIDO VICENTE JR Chief Executive Officer | 2021-02-25 18:17:22 | 233,396 10,500 | 243,896 | Form 4 |
| 8 | MITRO THOMAS A President and COO | 2022-02-09 19:41:16 | 81,418 0 | 81,418 | Form 4 |
| 9 | LEVY BRIAN Chief Medical Officer | 2015-02-27 18:28:45 | 78,188 0 | 78,188 | Form 4 |
| 10 | GOLDBERG MURRAY A Director | 2020-05-20 18:45:27 | 36,050 0 | 36,050 | Form 4 |
| 11 | Conway Janet L. Director | 2013-10-25 19:07:22 | 33,434 0 | 33,434 | Form 3 |
| 12 | Hollander David Chief R&D Officer | 2022-02-08 20:40:33 | 30,749 0 | 30,749 | Form 4 |
| 13 | Mack David Henry Director | 2013-11-19 16:28:31 | 28,000 0 | 28,000 | Form 3/A |
| 14 | Cagle Gerald D. Director | 2021-06-21 16:15:56 | 27,850 0 | 27,850 | Form 4 |
| 15 | MAZZO JAMES V Director | 2014-06-13 21:32:40 | 25,000 0 | 25,000 | Form 4 |
| 16 | MCGINLEY KATHLEEN CHRO & VP, Corp Services | 2022-02-01 17:08:49 | 23,993 0 | 23,993 | Form 4 |
| 17 | Staten Christopher Interim CFO | 2021-08-17 16:54:15 | 21,710 0 | 21,710 | Form 4 |
| 18 | DUYK GEOFFREY M Director | 2017-02-16 16:03:20 | 6,733 0 | 6,733 | Form 4 |
| 19 | McHugh Julie Director | 2022-11-21 16:59:15 | 0 0 | 0 | Form 4 |
| 20 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. DEERFIELD PARTNERS L.P. Possible Member of a 10% Group 10% Owner | 2023-02-10 10:00:04 | 0 0 | 0 | Form 13G |
| 21 | MCGRAW BENJAMIN F III Director | 2022-11-21 16:57:44 | 0 0 | 0 | Form 4 |
| 22 | McDonnell Peter J Director | 2022-11-21 16:56:06 | 0 0 | 0 | Form 4 |
| 23 | Kopczynski Casey C. Chief Scientific Officer | 2022-11-21 16:54:47 | 0 0 | 0 | Form 4 |
| 24 | Lang Peter Frederick Chief Financial Officer | 2022-11-21 16:52:39 | 0 0 | 0 | Form 4 |
| 25 | LaRocca John General Counsel | 2022-11-21 16:47:06 | 0 0 | 0 | Form 4 |
| 26 | GRYSKA DAVID W Director | 2022-11-21 16:43:42 | 0 0 | 0 | Form 4 |
| 27 | du Toit Michael Director | 2022-11-21 16:41:06 | 0 0 | 0 | Form 4 |
| 28 | Croarkin Richard Director | 2022-11-21 16:37:41 | 0 0 | 0 | Form 4 |
| 29 | Calabrese Jeffrey Vice President of Finance | 2022-11-21 16:34:24 | 0 0 | 0 | Form 4 |
| 30 | KANNAN RAJ Chief Executive Officer | 2022-11-21 16:30:33 | 0 0 | 0 | Form 4 |
| 31 | Clarus Lifesciences II L.P. Clarus Ventures II GP L.P. Clarus Ventures II LLC GALAKATOS NICHOLAS HENNER DENNIS LIPTAK ROBERT Simon Nicholas STEINMETZ MICHAEL WHEELER KURT 10% Owner | 2015-02-23 17:14:23 | 0 0 | 0 | Form 13D |